The Pacific’s response to the COVID-19 outbreak is likely to lead to increased scrutiny of health budgets and investments in our region.
However first there are the very pressing questions of how to scale up response in individual countries and territories, best leverage regional expertise and cooperation, maintain public health messaging that is relevant to Pacific communities, and prepare for second and subsequent waves of infection.
When Islands Business first interviewed Sunia Soakai, the Deputy Director, Public Health Division, at the Pacific Community, only five countries had COVID-19 testing capabilities: Fiji, French Polynesia, New Caledonia, Guam and Papua New Guinea. Since then other Pacific locations have come online. Palau has begun random testing with equipment donated by Taiwan. American Samoa is doing limited local testing, while still sending samples to Hawaii. The Northern Marianas has taken delivery of kits from a South Korean manufacturer, and its government aims to test every resident.
The most efficient way of facilitating local testing in our region, says Soakai, is to use custom-made cartridges in machines already in place for TB testing. The joint Incident Management Team of which SPC is a member (see p13) has placed orders for the cartridges and the consumables that go with them.
“No firm date has been set by the manufacturer [for delivery]” Soakai says, “but given that the Pacific is a region that has limited capacity, WHO and UNICEF have provided their support and the manufacturer has agreed to provide priority for the Pacific.”